10.29.07
Gibraltar Laboratories Inc., (GBL) a life science CGMP/ISO 17025 testing and consulting firm, has completed the first phase of a 14,000-sq.-ft. expansion of its laboratory facilities.
The company currently owns and occupies 12,000 square feet at 122 Fairfield Rd. in Fairfield, NJ. The expansion, to a nearby wholly owned cite provides Gibraltar with new microbiology laboratories to perform compendial pharmaceutical, medical device, virus testing, Mycoplasma, cell culture, packaging and biotechnology services. It includes both a large cleanroom for USP <71> Sterility Testing and a large BSL-3 laboratory for microbial/viral control.
The new laboratory affords Gibraltar an additional 4,000 sq. ft. of chemistry analytical laboratory space at the 122 Fairfield Rd. site. This analytical space will house raw materials testing and Atomic Absorption.
The expansion, to be completed in December 2007, is expected to generate approximately 10-20 new jobs for skilled professionals in areas of Microbiology, Chemistry and Quality Assurance, according to Dr. Daniel Prince, GBL's president.
The company currently owns and occupies 12,000 square feet at 122 Fairfield Rd. in Fairfield, NJ. The expansion, to a nearby wholly owned cite provides Gibraltar with new microbiology laboratories to perform compendial pharmaceutical, medical device, virus testing, Mycoplasma, cell culture, packaging and biotechnology services. It includes both a large cleanroom for USP <71> Sterility Testing and a large BSL-3 laboratory for microbial/viral control.
The new laboratory affords Gibraltar an additional 4,000 sq. ft. of chemistry analytical laboratory space at the 122 Fairfield Rd. site. This analytical space will house raw materials testing and Atomic Absorption.
The expansion, to be completed in December 2007, is expected to generate approximately 10-20 new jobs for skilled professionals in areas of Microbiology, Chemistry and Quality Assurance, according to Dr. Daniel Prince, GBL's president.